|
PT88641B
(pt)
|
1987-10-02 |
1993-04-30 |
Genentech Inc |
Metodo para a preparacao de uma variante de adesao
|
|
GB8909916D0
(en)
|
1989-04-29 |
1989-06-14 |
Delta Biotechnology Ltd |
Polypeptides
|
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
WO1999047556A2
(en)
*
|
1998-03-19 |
1999-09-23 |
Trustees Of Tufts College |
Novel heparin-induced ccn-like molecules and uses therefor
|
|
JP4202128B2
(ja)
*
|
2000-10-16 |
2008-12-24 |
ジェネンテック・インコーポレーテッド |
Ｗｉｓｐポリペプチドを用いる治療方法
|
|
CN1835763B
(zh)
|
2003-06-20 |
2011-04-20 |
妙甯公司 |
Ccn1组合物和方法
|
|
FR2858234B1
(fr)
*
|
2003-08-01 |
2007-09-14 |
Centre Nat Rech Scient |
Nouvel agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers
|
|
EP1771467A2
(en)
|
2004-07-26 |
2007-04-11 |
Asterion Limited |
Linkers
|
|
ES2395260T3
(es)
*
|
2005-01-10 |
2013-02-11 |
Rosalind Franklin University Of Medicine And Science |
Proteína CCN3 para su utilización en el tratamiento y el diagnóstico de enfermedades renales
|
|
DK1853631T3
(en)
*
|
2005-01-24 |
2016-03-29 |
Univ Texas |
Fc-FUSION CONSTRUCTIONS BINDING TO PHOSPHATIDYLSERINE AND THERAPEUTIC APPLICATION THEREOF
|
|
US20100144641A1
(en)
|
2005-09-12 |
2010-06-10 |
Popel Aleksander S |
Compositions Having Antiangiogenic Activity and Uses Thereof
|
|
JP2009067678A
(ja)
*
|
2005-12-07 |
2009-04-02 |
Nihon Nosan Kogyo Kk |
結合組織増殖因子に対する抗体又はそれを含む組成物
|
|
US20080207489A1
(en)
|
2007-02-21 |
2008-08-28 |
John Castellot |
Use of CCN5 for treatment of smooth muscle proliferation disorders
|
|
WO2009086132A2
(en)
|
2007-12-20 |
2009-07-09 |
University Of Southern California |
Design of spacers to increase the expression of recombinant fusion proteins
|
|
DK3061817T3
(en)
*
|
2009-04-30 |
2019-03-04 |
Kao Corp |
Alkaline protease variants
|
|
TW201102086A
(en)
|
2009-06-04 |
2011-01-16 |
Hoffmann La Roche |
Antibodies against human CCN1 and uses thereof
|
|
CA2773737C
(en)
|
2009-09-09 |
2021-11-16 |
Pharmain Corporation |
Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
|
|
ES2688978T3
(es)
|
2009-11-23 |
2018-11-07 |
Amgen Inc. |
Anticuerpo monomérico Fc
|
|
KR101187814B1
(ko)
|
2010-03-22 |
2012-10-08 |
광주과학기술원 |
심부전 예방 또는 치료용 약제학적 조성물 및 심부전 예방 또는 치료제의 스크리닝 방법
|
|
EP2552462B1
(en)
|
2010-04-02 |
2015-12-16 |
Rosalind Franklin University of Medicine and Science |
Ccn3 peptides and analogs thereof for therapeutic use
|
|
US9114112B2
(en)
*
|
2010-04-02 |
2015-08-25 |
Rosalind Franklin University Of Medicine And Science |
CCN3 and CCN3 peptides and analogs thereof for therapeutic uses
|
|
ES2630031T3
(es)
*
|
2010-09-28 |
2017-08-17 |
Aegerion Pharmaceuticals, Inc. |
Un polipéptido de leptina pinnípedo-humano quimérico con solubilidad aumentada
|
|
CA2822366A1
(en)
|
2010-12-23 |
2012-06-28 |
Janssen Biotech, Inc. |
Active protease-resistant antibody fc mutants
|
|
WO2014008582A1
(en)
|
2012-07-11 |
2014-01-16 |
The University Of Western Ontario |
Method of treating wounds with penostin and/or ccn2
|
|
US20140271641A1
(en)
|
2013-03-14 |
2014-09-18 |
University Of Guelph |
Thrombospondin-1 polypeptides and methods of using same
|
|
GB201316592D0
(en)
|
2013-09-18 |
2013-10-30 |
Levicept Ltd |
Fusion protein
|
|
EP3842451A1
(en)
|
2015-03-12 |
2021-06-30 |
MedImmune, LLC |
Method of purifying albumin-fusion proteins
|
|
WO2016197071A1
(en)
|
2015-06-05 |
2016-12-08 |
New York University |
Compositions and methods for anti-staphylococcal biologic agents
|
|
GB201512733D0
(en)
|
2015-07-20 |
2015-08-26 |
Genagon Therapeutics Ab |
Therapeutic agents for treating conditions associated with elevated GDF15
|
|
CN105396136B
(zh)
*
|
2015-11-23 |
2018-10-30 |
上海交通大学医学院附属第九人民医院 |
CCN1（Cyr61）在治疗皮肤损伤及皮肤萎缩相关疾病中的应用
|
|
EP3192806A1
(en)
|
2016-01-13 |
2017-07-19 |
Affiris AG |
Alpha chain of the high-affinity ige receptor (fceria)
|
|
AU2017232546B2
(en)
|
2016-03-14 |
2024-05-02 |
Universitetet I Oslo |
Engineered immunoglobulins with altered FCRN binding
|
|
US10028906B2
(en)
|
2016-03-22 |
2018-07-24 |
Rosalind Franklin University Of Medicine And Science |
Method and kit for treating a solid tumor and associated desmoplasia
|
|
EP3494128B1
(en)
|
2016-08-04 |
2023-11-29 |
Stichting VUmc |
Embryonic angiogenesis markers and diagnostic and therapeutic strategies based thereon
|
|
US20180127478A1
(en)
|
2016-09-16 |
2018-05-10 |
Wei-Chiang Shen |
SINGLE CHAIN Fc-DIMER-HUMAN GROWTH HORMONE FUSION PROTEIN FOR IMPROVED DRUG DELIVERY
|
|
KR20180099537A
(ko)
*
|
2017-02-28 |
2018-09-05 |
주식회사 파이안바이오테크놀로지 |
근섬유모세포의 병리적 활성이 초래하는 섬유증식성 질병 치료제
|
|
KR102008407B1
(ko)
|
2017-09-05 |
2019-08-08 |
한국생명공학연구원 |
코돈 최적화된 il-21 및 이의 용도
|
|
WO2019071007A1
(en)
|
2017-10-05 |
2019-04-11 |
New York Genome Center, Inc. |
METHODS AND COMPOSITIONS FOR TARGETING VASCULAR MIMETTISM
|